Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease

Characterising Alzheimer’s disease (AD) as a metabolic disorder of the brain is gaining acceptance based on the pathophysiological commonalities between AD and major metabolic disorders. Therefore, metabolic interventions have been explored as a strategy for brain energetic rescue. Amongst these, me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameen, Aishat O., Freude, Kristine, Aldana, Blanca I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687972/
https://www.ncbi.nlm.nih.gov/pubmed/36359298
http://dx.doi.org/10.3390/biomedicines10112778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687972/
https://www.ncbi.nlm.nih.gov/pubmed/36359298
http://dx.doi.org/10.3390/biomedicines10112778

Ejemplares similares